ÑÇÖÞ×ÔοÊÓƵ

Amir M. Arain
( out of 103 reviews )

Amir M. Arain, MD, MPH

Languages spoken: Arabic, Urdu, English

Clinical Locations

Clinical Neurosciences Center

Salt Lake City
801-585-7575

  • Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt ÑÇÖÞ×ÔοÊÓƵ. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined ÑÇÖÞ×ÔοÊÓƵ of Utah in July 2018 and currently serves as chief of Epilepsy division.

    Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.

    Specialties

    Board Certification

    American Board of Clinical Neurophysiology
    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Clinical Neurophysiology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Patient Rating

    4.6 /5
    ( out of 103 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 29, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Arian is a amazing doctor to see I have been seeing him for 5 years now and he has helped me and taken really good care of me and my needs I will recommend him to anyone keep up the good work Dr Arian

    October 24, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr Arian is great. He listens carefully and then answers in regular, understandable language!

    October 12, 2024
    CLINICAL NEUROSCIENCES CENTER

    Fantastic experience! I can't express how grateful we are that he was our provider.

    September 28, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Arain is the best neurologist I've ever seen! Trust me, I've been to a lot of them. He shows deep concern for his pt's and will get the info you need , and the amazing care that we deserve as pt's. I am very excited to continue my neuro journey with him and his staff.

    September 05, 2024
    CLINICAL NEUROSCIENCES CENTER

    Very nice and helpful and listened to me and answered all my questions

    July 24, 2024
    CLINICAL NEUROSCIENCES CENTER

    Desde que el doctor Amir trata a nuestra hija, ella ha estado mucho mejor, y con mejor salud qué antes, nosotros agradecemos a el por su atención, y lo recomendamos ampliamente.

    July 17, 2024
    CLINICAL NEUROSCIENCES CENTER

    The doctor dismissed my concerns almost immediately. He wouldn't listen to me or my concerns and repeatedly asked me if I was going to Therapy and seeing a psychiatrist. He made me feel like my symptoms were fake and didn't matter. I would not recommend this provider to anyone especially any females.

    July 04, 2024
    CLINICAL NEUROSCIENCES CENTER

    We trust Dr Arain to care for Clint and all his needs. He never talks down nor does he speak in medical terms Clint doesn't understand. We trust him, we like him and wouldn't think of seeing another Doctor for [NAME REMOVED].

    July 03, 2024
    CLINICAL NEUROSCIENCES CENTER

    I like how he truly knows what is going on with my brain and tells me what is the best outcome.

    See More Patient Comments

  • Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt ÑÇÖÞ×ÔοÊÓƵ. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined ÑÇÖÞ×ÔοÊÓƵ of Utah in July 2018 and currently serves as chief of Epilepsy division.

    Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.

    Board Certification and Academic Information

    Academic Departments Neurology -Primary
    Board Certification
    American Board of Clinical Neurophysiology
    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Clinical Neurophysiology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Education history

    Graduate Training Epidemiology, Biostatistics, Clinical Research Design, etc - Vanderbilt ÑÇÖÞ×ÔοÊÓƵ M.P.H.
    Epilepsy/Neurophysiology - Vanderbilt ÑÇÖÞ×ÔοÊÓƵ Medical Center Clinical Fellow
    Chief Resident Neurology - Vanderbilt ÑÇÖÞ×ÔοÊÓƵ Medical Center Chief Resident
    Neurology - Vanderbilt ÑÇÖÞ×ÔοÊÓƵ Medical Center Resident
    Internship Internal Medicine - McLaren Flint Intern
    Medicine, Surgery - Dow Medical College of the ÑÇÖÞ×ÔοÊÓƵ of Karachi M.B.B.S.

    Selected Publications

    Journal Article

    1. Anderson DN, Charlebois CM, Smith EH, Davis TS, Peters AY, Newman BJ, Arain AM, Wilcox KS, Butson CR, Rolston JD (2023). Closed-loop stimulation in periods with less epileptiform activity drives improved epilepsy outcomes. Brain, 147(2), 521-531. ()
    2. Campbell JM, Kundu B, Lee JN, Miranda M, Arain A, Taussky P, Grandhi R, Rolston JD (2022). Evaluating the concordance of functional MRI-based language lateralization and Wada testing in epilepsy patients: A single-center analysis. Interv Neuroradiol, 29(5), 599-604. ()
    3. Simon A, Nguyen D, Newman B, Arain A (2023). Uric Acid Nephropathy Secondary to Generalized Tonic-Clonic Seizures. Neurologist. ()
    4. Kundu B, Arain A, Davis T, Charlebois CM, Rolston JD (2022). Using chronic recordings from a closed-loop neurostimulation system to capture seizures across multiple thalamic nuclei. Ann Clin Transl Neurol, 10(1), 136-143. ()
    5. Charlebois CM, Anderson DN, Johnson KA, Philip BJ, Davis TS, Newman BJ, Peters AY, Arain AM, Dorval AD, Rolston JD, Butson CR (2022). Patient-specific structural connectivity informs outcomes of responsive neurostimulation for temporal lobe epilepsy. Epilepsia, 63(8), 2037-2055. ()
    6. Miranda M, Arias F, Arain A, Newman B, Rolston J, Richards S, Peters A, Pick LH (2022). Neuropsychological evaluation in American Sign Language: A case study of a deaf patient with epilepsy. Epilepsy Behav Rep, 19, 100558. ()
    7. Brown MG, Sillau S, McDermott D, Ernst LD, Spencer DC, Englot DJ, Gonzlez HFJ, Datta P, Karakis I, Becker D, Rolston JD, Arain A, Rao VR, Doherty M, Urban A, Drees C (2022). Concurrent brain-responsive and vagus nerve stimulation for treatment of drug-resistant focal epilepsy. Epilepsy Behav, 129, 108653. ()
    8. Anderson DN, Charlebois CM, Smith EH, Arain AM, Davis TS, Rolston JD (2021). Probabilistic comparison of gray and white matter coverage between depth and surface intracranial electrodes in epilepsy. Sci Rep, 11(1), 24155. ()
    9. Jehi L, Morita-Sherman M, Love TE, Bartolomei F, Bingaman W, Braun K, Busch RM, Duncan J, Hader WJ, Luan G, Rolston JD, Schuele S, Tassi L, Vadera S, Sheikh S, Najm I, Arain A, Bingaman J, Diehl B, de Tisi J, Rados M, Van Eijsden P, Wahby S, Wang X, Wiebe S (2021). Comparative Effectiveness of Stereotactic Electroencephalography Versus Subdural Grids in Epilepsy Surgery. Ann Neurol, 90(6), 927-939. ()
    10. Frankel MA, Lehmkuhle MJ, Spitz MC, Newman BJ, Richards SV, Arain AM (2021). Wearable Reduced-Channel EEG System for Remote Seizure Monitoring. Front Neurol, 12, 728484. ()
    11. Scoville JP, Joyce E, Hunsaker J, Reese J, Wilde H, Arain A, Bollo RL, Rolston JD (2020). Stereotactic Electroencephalography Is Associated With Reduced Pain and Opioid Use When Compared with Subdural Grids: A Case Series. Oper Neurosurg (Hagerstown), 21(1), 6-13. ()
    12. Kundu B, Davis TS, Philip B, Smith EH, Arain A, Peters A, Newman B, Butson CR, Rolston JD (2020). A systematic exploration of parameters affecting evoked intracranial potentials in patients with epilepsy. Brain Stimul, 13(5), 1232-1244. ()
    13. Bornali Kundu, Tyler S Davis, Brian Philip, Elliot H Smith, Amir Arain, Angela Peters, Blake Newman, Christopher R Butson, John D Rolston (2020). A systematic exploration of parameters affecting evoked intracranial potentials in patients with epilepsy. Brain Stimul, 13(5), 1232-1244.
    14. Zaher N, Haas K, Sonmezturk H, Arain A, Abou-Khalil B (2019). Rhythmic ictal nonclonic hand (RINCH) motions in general EMU patients with focal epilepsy. Epilepsy Behav, 103(Pt A), 106666. ()
    15. Naoir Zaher, Kevin Haas, Hasan Sonmezturk, Amir Arain, Bassel Abou-Khalil (2019). Rhythmic ictal nonclonic hand (RINCH) motions in general EMU patients with focal epilepsy. Epilepsy Behav, Feb. 2020, 103 pt. A.
    16. Arain AM, Umar A, Rawal P, Azar NJ, Obideen M, Singh P, Al-Kaylani M, Abou-Khalil B (2018). Localization value of ictal turning prone. Seizure, 69, 57-60. ()
    17. Halford JJ, Westover MB, LaRoche SM, Macken MP, Kutluay E, Edwards JC, Bonilha L, Kalamangalam GP, Ding K, Hopp JL, Arain A, Dawson RA, Martz GU, Wolf BJ, Waters CG, Dean BC (2018). Interictal Epileptiform Discharge Detection in EEG in Different Practice Settings. J Clin Neurophysiol, 35(5), 375-380. ()
    18. Baker MD, Abou-Khalil BW, Arain A, Tummala P, Azar NJ, Haas KF, Sonmezturk HH (2018). Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center. Clin Neurol Neurosurg, 171, 179-183. ()
    19. Sagi V, Kim I, Bhatt AB, Sonmezturk H, Abou-Khalil BW, Arain AM (2017). Generalized paroxysmal fast activity in EEG: An unrecognized finding in genetic generalized epilepsy. Epilepsy Behav, 76, 101-104. ()

  • News & Podcasts

    Podcasts

  • Clinical Trials